Byrja\u00f0u \u00e1 250 mg af NMN e\u00f0a NR einu sinni \u00e1 dag a\u00f0 morgni, haldi\u00f0 \u00fea\u00f0 tv\u00ed frest, d\u00f3mi\u00f0 svo v\u00f6ruvara eftir fj\u00f3ra til sex vikur. Hvert NAD-vi\u00f0b\u00f3tsefni sem selt er er formverki, ekki NAD+ sj\u00e1lft. \u00deessar v\u00f6rur auka bl\u00f3\u00f0 NAD+ \u00e1rei\u00f0anlega. Engin ranns\u00f3kn \u00e1 m\u00e6li s\u00ednir a\u00f0 \u00fea\u00f0 lengi lif\u00e6i.

\u00TL;DR: Helstu ni\u00f0urst\u00f6\u00f0ur

  • \u00de\u00fa getur ekki keypt NAD+. \u00de\u00fa kaupir NMN, NR e\u00f0a nik\u00f3t\u00ednam\u00ed\u00f0, og frumur \u00fe\u00ednar byggja NAD+ aftur upp fr\u00e1 \u00fev\u00ed.
  • 250 til 500 mg \u00e1 dag n\u00e1 \u00fct \u00f6rst a\u00f0ila. Yfir 1.000 mg \u00e1 dag kaupir \u00f3kunna, ekki \u00e1vinning.
  • Morgunskammtur, fastandi maga ef \u00feolandi, og erfi\u00f0ur \u00e1kva\u00f0arpunktur eftir fj\u00f3ra til sex vikur.
  • \u00deri\u00f0ja-a\u00f0ila vottun (NSF, USP, ConsumerLab) skiptir meira m\u00e1li en hva\u00f0 formverki \u00fea\u00f0 er vali\u00f0.
  • \u00f6rt\u00edma \u00feolandi er gott. Fj\u00f6l\u00e1ra \u00f6ryggisg\u00f6gn liggja ekki fyrir enn.

NAD-vi\u00f0b\u00f3tsefni inniheldur ekki NAD+, og \u00fea\u00f0 er punkturin

Sert NAD-vi\u00f0b\u00f3tsefni \u00e1 hillunni er formverki vara. \u00de\u00fa kaupir NMN, NR e\u00f0a bara nik\u00f3t\u00ednam\u00ed\u00f0, byrjar \u00e1 250 mg einu sinni \u00e1 dag a\u00f0 morgni, heldur \u00feeim skammti \u00ed tv\u00ed vikur, og metur aftur eftir fj\u00f3rur til sex vikur. NAD+ sj\u00e1lft er ekki innihaldsefni\u00f0, vegna \u00f3h\u00e6fni\u00f0ar \u00feess sem heil molek\u00fala a\u00f0 komast yfir frumuhrim, svo frumur \u00fe\u00ednar byggja \u00fea\u00f0 aftur upp fr\u00e1 hva\u00f0 sem er formverki sem \u00feu\u00f0 gleypir.

\u00dea\u00f0 vandam\u00e1l me\u00f0 hr\u00edm er grundvallar sta\u00f0reynd flokksins, og Jinfiniti's skammtalei\u00f0beiningar gera \u00fea\u00f0 beinl\u00ednis: NAD+ sem er gleypt e\u00f0a gefi\u00f0 inn kemur ni\u00f0ur \u00ed formverki \u00e1\u00f0ur en nokkur fruma getur n\u00fatsla \u00fea\u00f0. Afhendingarform breytir hversu miki\u00f0 formverki kemur, ekki hva\u00f0 gerist n\u00e6st. Goldman Laboratories setur venjulega munnsognu uppt\u00f6ku \u00e1 um \u00fea\u00f0 bil 10 til 20 pr\u00f3sent og \u00feynnsluf\u00f6rm n\u00e1lega 60 pr\u00f3sent, t\u00f6lur sem eru ver\u00f0ar a\u00f0 me\u00f0fara sem \u00e1lit seljanda frekar en sta\u00f0fest lyfjafr\u00e6\u00f0i.

\u00derj\u00fa formverki fj\u00f6lskyldur, beint: NMN, NR, og gamlar B3-v\u00edtam\u00edn ger\u00f0ir, nik\u00f3t\u00ednam\u00ed\u00f0 (niacinamide) og n\u00edasin. Venjuleg r\u00f6k fyrir a\u00f0 taka einhverja \u00f0eirra eru um \u00fea\u00f0 bil 50 pr\u00f3sent l\u00edffall NAD+ milli 20 og 50 \u00e1ra aldurs, tala sem Goldman Laboratories og meirihluti i\u00f0na\u00f0arins vitnar \u00ed.

NAD+ \u00e1vinningur birtist \u00e1 bl\u00f3\u00f0pr\u00f3fum, ekki enn lif\u00e6i

Skr\u00e1\u00f0i NAD+ \u00e1vinningur stoppar vi\u00f0 bl\u00f3\u00f0pr\u00f3fi\u00f0. 2022 endursko\u00f0un ranns\u00f3kna \u00e1 m\u00e6li sem eyka NAD+ fann a\u00f0 NR og NMN auka bl\u00f3\u00f0 og frumu NAD+ \u00e1rei\u00f0anlega og eru almennt vel \u00feolin yfir vikur til m\u00e1nu\u00f0a, og a\u00f0 engin ranns\u00f3kn \u00e1 m\u00e6li hefur s\u00fdnt a\u00f0 \u00fea\u00f0 lengi lif\u00e6i, minnki d\u00fau\u00f0a, e\u00f0a me\u00f0h\u00f6ndli aldurtengda sj\u00fav\u00e6fni.

G\u00f6gn d\u00fdranna eru minna f\u00e1gur en marka\u00f0ssetning gefur \u00ed skyn. \u00cd ranns\u00f3kn \u00e1 m\u00fssum \u00e1ri\u00f0 2018 b\u00e6tti nik\u00f3t\u00ednam\u00ed\u00f0 merki um heilsu\u00f0arlif (minni fitulifur, betri gl\u00fakk\u00f3sa skil, minna oxunarskemmdir) en lengdi ekki l\u00e6gsta l\u00e6gsta lif\u00e6i.

H\u00e9rna er \u00fea\u00f0 sem flestir s\u00ed\u00f0ur munu ekki segja \u00fe\u00e9r: \u00feegar \u00feu\u00f0 les um NAD+ \u00e1vinning \u00ed v\u00f6ru afriti, eru sannanirnar undir n\u00e1stum alltaf frumus\u00f6fnun e\u00f0a nagd\u00fdr, og nagd\u00fdratilraunin n\u00e1nast lengingarkr\u00f6fu n\u00e1\u00f0i ekki lengingu.

Svo d\u00f3murinn er \u00f3takmarka\u00f0ur og gagnlegur. Me\u00f0h\u00f6ndla NAD-vi\u00f0b\u00f3tsefni sem \u00f3sanna\u00f0 efnaskiptastu\u00f0ningsvara, ekki lengingarlyf eins og flokkurinn er seldur sem.

Skref 1: Veldu formverki\u00f0 \u00feitt eftir hver \u00feu\u00f0 ert, ekki eftir hver s\u00e1 n\u00fdjastur

Spurningin NMN \u00ed m\u00f3ti NR er raunveruleg spurning um \u00feig, ekki um m\u00f3lek\u00falana. Goldman Laboratories setur NMN fram sem dreifist um allan l\u00edkamann og NR sem meira lifrar\u00feunga\u00f0, sanngjarnt vinnul\u00f6g sem engin ranns\u00f3kn \u00e1 m\u00e6li hefur sta\u00f0fest sem kl\u00edniskt markt\u00e6kt. \u00dea\u00f0 sem er sannarlega sta\u00f0fest er papp\u00edrsr\u00e1\u00f0i\u00f0: NR hefur veri\u00f0 marka\u00f0 lengst og ber d\u00fbpstu g\u00f6gn um skammta \u00e1 m\u00e6li, \u00fear me\u00f0al f\u00e1lka-stj\u00f3rnu\u00f0 ranns\u00f3knum. NMN hefur sitt eigi\u00f0 tilviljunarkennd, tv\u00edblind, f\u00e1lka-stj\u00f3rnu\u00f0 skammtaranns\u00f3kn \u00ed heilbrig\u00f0um mi\u00f0aldra fullor\u00f0num, sem fann \u00fea\u00f0 vera vel \u00feoli\u00f0 me\u00f0 engin \u00f6ryggismerki var\u00f0andi aukaverkanir e\u00f0a ranns\u00f3knir.

A\u00f0skilja eftir \u00e1 sni\u00f0i. Ef kostna\u00f0ur er bindandi takm\u00f6rk, kaupa nik\u00f3t\u00ednam\u00ed\u00f0, \u00f3d\u00fdrasta lei\u00f0 inn \u00ed sama ferli. Fyrir almenna notkun yfir 50, NMN vi\u00f0b\u00f3tsefni e\u00f0a NR \u00e1 250 til 500 mg \u00e1 dag er fj\u00f6lmennasta vali\u00f0. Ef \u00fe\u00ednn \u00e1hugi er efnaskipta- e\u00f0a lifrarheilbrig\u00f0i, NR \u00e1 300 mg \u00e1 dag hefur mest g\u00f6gn \u00e1 m\u00e6li a\u00f0 baki s\u00ednu. Ef \u00fe\u00ednn \u00e1hugi er \u00ed hú\u00f0, nik\u00f3t\u00ednam\u00ed\u00f0.

Engin bein ranns\u00f3kn \u00e1 m\u00e6li hefur sta\u00f0fest eitt formverki sem betra. L\u00e1ti\u00f0 sni\u00f0 og ver\u00f0 r\u00e1\u00f0a, ekki n\u00fdjungar.

Skref 2: Byrja\u00f0u \u00e1 250 mg og klifra\u00f0u bara ef \u00feu\u00f0 hefur \u00e1st\u00e6\u00f0u til

NAD+ skammtar er \u00fea\u00f0 sem \u00fea\u00f0 "meira er betra" \u00ed\u00f0sthugunin gerir mestan ska\u00f0a. \u00cd f\u00e1lka-stj\u00f3rnu\u00f0 ranns\u00f3kn \u00e1 nik\u00f3t\u00ednam\u00ed\u00f0 r\u00edb\u00f3s\u00ed\u00f0, 100, 300, og 1.000 mg \u00e1 dag \u00e1ttu heildarbl\u00f3\u00f0 NAD+ um 22 pr\u00f3sent, 51 pr\u00f3sent, og 142 pr\u00f3sent innan tveggja vikna, me\u00f0 engum markt\u00e6kum mun \u00e1 aukaverkunum vi\u00f0 f\u00e1lka. Lesi\u00f0 kreppuna vandlega. Bl\u00f3\u00f0 tala heldur \u00e1fram a\u00f0 klifra. Ekkert \u00ed ranns\u00f3kninni s\u00fdnir a\u00f0 auka klifri\u00f0 geri neitt fyrir \u00feig.

Jinfiniti nefnir innfrumugrindar skotmark um \u00fea\u00f0 bil 40 til 100 \u03bcM. \u00de\u00f3tt \u00e1 eitthva\u00f0 sem \u00feu\u00f0 getur gert: flestir lenda \u00ed \u00fev\u00ed svi\u00f0i \u00e1 um \u00fea\u00f0 bil 250 til 500 mg \u00e1 dag af NMN e\u00f0a NR. Yfir \u00fea\u00f0 bil um 1.000 mg \u00e1 dag er enginn sta\u00f0festur auka\u00e1vinningur og lengri listi yfir \u00f3kunna.

Virkt NAD+ skammtar s\u00edgur l\u00edtur svona \u00fat. Taktu 150 til 250 mg \u00e1 dag \u00ed tv\u00ed vikur. Ef \u00feu\u00f0 \u00feolir \u00fea\u00f0 og hefur \u00e1st\u00e6\u00f0u til a\u00f0 fara h\u00e6rra, f\u00e6r\u00f0u \u00feig \u00e1 300 til 500 mg \u00e1 dag. Ef ro\u00f0i, \u00f3gle\u00f0i, e\u00f0a h\u00f6fu\u00f0verkur birtast, f\u00e6r\u00f0u \u00feig aftur upp \u00e1 s\u00ed\u00f0asta skammt sem lei\u00f0st vel og haltu \u00fear.

H\u00e1markin eru \u00e1rei\u00f0anlegar eins langt og \u00fea\u00f0 n\u00e1. Oregon State's Linus Pauling Institute \u00fetir ranns\u00f3knir \u00fear sem NR var \u00feoli\u00f0 upp \u00e1 2.000 mg \u00e1 dag \u00ed 12 vikur hj\u00e1 fullor\u00f0num me\u00f0 offituleysi, me\u00f0 a\u00f0eins minnih\u00e1ttar svitakast og v\u00e6gir meltingar-\u00f3l\u00f6g, og \u00fear sem 250 til 500 mg \u00e1 dag s\u00fdndi hagst\u00e6tt \u00f6ryggissni\u00f0 \u00ed fullor\u00f0num 60 til 80 \u00e1ra.

Ein tala sem ekki skal misskilja: Leyfilegt efra inntaka stig fyrir n\u00edasin er 35 mg \u00e1 dag fyrir fullor\u00f0na, sett s\u00e9rt\u00e6kt til a\u00f0 for\u00f0ast ro\u00f0a. \u00dea\u00f0 gildir um B3-v\u00edtam\u00edn ger\u00f0ir. \u00dea\u00f0 er ekki h\u00e1mark fyrir NR e\u00f0a NMN, sem hafa engin alr\u00edkis\u00f6ryggism\u00e1l.

Skref 3: Taktu \u00fea\u00f0 a\u00f0 morgni, og gef\u00f0u \u00fev\u00ed sex vikur \u00e1\u00f0ur en \u00feu\u00f0 d\u00f3mir

Taktu skammtinn \u00feinn a\u00f0 morgni, helst fastandi maga um 30 m\u00edn\u00f3tum fyrir mat. Ef \u00fea\u00f0 gerir \u00feig \u00e1rei\u00f0anlega \u00f3gl\u00f3tan, taktu \u00fea\u00f0 me\u00f0 mat og sam\u00faykktu d\u00edt\u00f0a uppt\u00f6ku, sem er betra skipti en a\u00f0 h\u00e6tta. A\u00f0 skipta \u00ed morgun- og kv\u00f6ldskammt er bara \u00feess vir\u00f0i yfir um 500 mg \u00e1 dag, og kv\u00f6lds\u00e1skammtur hefur engin sta\u00f0fest yfirbur\u00f0.

Svo settu frestinn sem enginn annar gefur \u00fe\u00e9r. Fj\u00f3rur til sex vikur \u00e1 jafnan skammti, s\u00e1\u00f0u svo: haltu \u00e1fram, breyttu, e\u00f0a h\u00e6ttu. "Gef\u00f0u \u00fev\u00ed t\u00edma" er hvernig f\u00e1lk ey\u00f0ir tv\u00f6 \u00e1r \u00e1 vi\u00f0b\u00f3tsefni sem \u00feau mettu aldrei.

Fyrir dag eitt, nefndu einn e\u00f0a tvo \u00fatraunir sem \u00feu\u00f0 getur raunverulega fylgst me\u00f0. M\u00e1ttur eftir h\u00e1degi, bata eftir erfi\u00f0a \u00f6kun, svefng\u00e6\u00f0i. Skrifa\u00f0u \u00fea\u00f0 ni\u00f0ur me\u00f0 t\u00f6lu \u00e1 hverjum degi, vegna \u00feess a\u00f0 minni mun \u00feegja sta\u00festa hva\u00f0 sem er sem \u00feu\u00f0 eyddir p\u00edningum \u00e1. Heilsu f\u00e9lagi app eins og August AI getur hj\u00e1lpa\u00f0 \u00fe\u00e9r a\u00f0 skr\u00e1 skammtinn \u00feinn og hvernig \u00feu\u00f0 finnur \u00f6ryggi dag eftir dag, sem aukab\u00fata vi\u00f0 eigin d\u00f3m og l\u00e6knis, aldrei sem hluturinn sem r\u00e1\u00f0ar skammtinum \u00fe\u00ednum.

St\u00f3kkun er \u00ed lagi. Ef \u00feu\u00f0 tekur n\u00f3ttskammt magnes\u00edum vi\u00f0b\u00f3tsefni, halda \u00fev\u00ed vi\u00f0 n\u00f3tt og formverki a\u00f0 morgni heldur \u00fea\u00f0 tveimur fr\u00e1 a\u00f0 drulla yfir hverjum \u00f6ðrum hli\u00f0ar \u00e1hrif.

Skref 3 haldi\u00f0 \u00e1fram: ef \u00fea\u00f0 er engin \u00feri\u00f0ja-a\u00f0ila innsigli, ger\u00f0u r\u00f6k fyrir a\u00f0 skammturinn \u00e1 mi\u00f0anum s\u00e9 r\u00f6ngur

NMN vi\u00f0b\u00f3tsefni marka\u00f0urinn hefur mi\u00f0avandam\u00e1l, og Goldman Laboratories vitnar \u00ed lotupr\u00f3funarg\u00f6gnum sem s\u00fdna v\u00f6rur sem yfirl\u00fdsa hversu miki\u00f0 virkt innihaldsefni \u00fea\u00f0 raunverulega inniheldur. \u00cd flokki \u00fear sem allt \u00fe\u00edtt \u00e1kv\u00e6mi er milligrama tala, \u00f3votta\u00f0 500 mg hylki er ekki skammtur. \u00dea\u00f0 er gisk.

Leita\u00f0u a\u00f0 NSF Certified for Sport, USP Verified, e\u00f0a ConsumerLab pr\u00f3fun \u00e1 tiltekinn v\u00f6ru, ekki \u00e1 or\u00f0spori vörumerkisins. Ef vara hefur engar \u00feri\u00f0ja-a\u00f0ila pr\u00f3fanir, kaupa annarri v\u00f6ru. Ekki auka skammtinn til a\u00f0 b\u00f3ta fyrir mi\u00f0a sem \u00feu\u00f0 hefur \u00fear \u00e1kve\u00f0i\u00f0 a\u00f0 \u00feu\u00f0 getur ekki treyst, sem er sama mi\u00f0a-traust gildra sem umlykur h\u00e1rv\u00f6xtar vi\u00f0b\u00f3tsefni eins og Nutrafol.

Og me\u00f0h\u00f6ndla hva\u00f0 sem er "eignarbl\u00f6ndu" sem ekki segir milligrömm \u00e1 formverki sem \u00f3notalegt. \u00de\u00fau getur ekki t\u00edtrera\u00f0 hva\u00f0 \u00feu\u00f0 getur ekki tali\u00f0.

IV NAD+ innrennsli eru \u00fe\u00e6g\u00f0arkaup, ekki sterkari skammtur

Jinfiniti setur IV lotur \u00e1 $300 til $800 hver, \u00e1 m\u00f3ti m\u00e1nu\u00f0ar af munnsognu formverki \u00e1 litlum brot af \u00fea\u00f0. Goldman Laboratories eigin t\u00f6lur undirk\u00f3pa for\u00f0rinn: n\u00e1lega 100 pr\u00f3sent alhli\u00f0a afhending, en a\u00f0eins um 2 pr\u00f3sent h\u00e1kk \u00e1 bl\u00f3\u00f0 NAD+ \u00e1 24 klukkustundum. Leyfi\u00f0 er frumu sta\u00f0reynd fr\u00e1 efstu hluta \u00fearar \u00f0essarar s\u00ed\u00f0u. Vegna \u00fea\u00f0 NAD+ getur ekki komist inn \u00ed frumur heil, innrennsla\u00f0 NAD+ er ey\u00f0 til sama formverki og hylki veitir. IV er \u00fea\u00f0 \u00fe\u00e6gindi og marka\u00f0sval, ekki yfirbur\u00f0arval.

NAD vi\u00f0b\u00f3tsefni hli\u00f0arverkanir eru mestmegnis v\u00e6gar, og \u00f3kunna eru raunverulega vandam\u00e1li\u00f0

Algengar NAD vi\u00f0b\u00f3tsefni hli\u00f0arverkanir eru skammtatengdar og daufar: ro\u00f0i, \u00f3gle\u00f0i, h\u00f6fu\u00f0verkur, og v\u00e6gir meltingar-\u00f3l\u00f6g, auk svitakast tilkynnt vi\u00f0 2.000 mg \u00e1 dag af NR. Ro\u00f0i er mestmegnis n\u00edasin fyrirb\u00e6ri. Linus Pauling Institute nefnir \u00fea\u00f0 geti komi\u00f0 fram me\u00f0 nik\u00f3t\u00ednsýru \u00e1 skammti allt ni\u00f0ur \u00e1 30 mg \u00e1 dag, \u00fear sem \u00fea\u00f0 er sjaldg\u00e6ft me\u00f0 nik\u00f3t\u00ednam\u00ed\u00f0.

Sveigurinn: \u00f6rt\u00edma \u00feolandi er ekki opin spurning. 2022 \u00f3vissu endursko\u00f0un merkir \u00ferj\u00fa hluti sem eru sannarlega \u00f3leystir, nefnilega m\u00f6guleg versnun gl\u00fakk\u00f3sa \u00f3p\u00e6gi, hugsanlegur krabbameins-aukandi \u00e1hrif hj\u00e1 f\u00f3lki me\u00f0 \u00f3tt\u00f0 krabbamein, og uppsöfnun ni\u00f0urbrotsafur\u00f0a 2-PY og MeNAM, sem l\u00e6gstu \u00e1hrif eru \u00f3kunna. S\u00e1 endursko\u00f0un er bein hva\u00f0 engar fj\u00f6l\u00e1ra ranns\u00f3knir \u00e1 m\u00e6li \u00e1 NR e\u00f0a NMN eru til. Mannleg g\u00f6gn n\u00e1 yfir vikur til nokkra m\u00e1nu\u00f0a, og f\u00e1lk tekur \u00fearri v\u00f6rur \u00ed \u00e1r.

Ef vi\u00f0brag\u00f0 er \u00f3þ\u00e6gilegt en greinilega ekki ney\u00f0artilfelli, \u00fev\u00e6gur h\u00f6fu\u00f0verkur e\u00f0a \u00f3gle\u00f0i sem hefur ekki sest eftir a\u00f0 \u00feu\u00f0 minnka\u00f0i skammtinn, August's 39$ net \u00f3leystur l\u00e6knis heims\u00f3kn getur fengi\u00f0 bandar\u00edska leyfisb\u00e6ran l\u00e6kni til a\u00f0 sko\u00f0a einkenni \u00fe\u00edn og vi\u00f0b\u00f3tsefni listann \u00feinn. L\u00e6knir\u00ednn \u00e1kve\u00f0ur hvort me\u00f0fer\u00f0 e\u00f0a lyfse\u00f0ill vi\u00f0eigandi.

Hven\u00e6r \u00e1 a\u00f0 h\u00e6tta vi\u00f0b\u00f3tsefni og hven\u00e6r a\u00f0 spyrja fyrst

\u00Hringdu \u00e1 911 e\u00f0a far\u00f0u \u00e1 br\u00e1\u00f0a\u00f0astofu n\u00fa ef:

  • \u00de\u00fau f\u00e6r\u00f0u andlits- e\u00f0a h\u00e1lsbolgu, ofsakla\u00e6kjur, e\u00f0a \u00f3tta eftir skammt e\u00f0a innrennsli.
  • \u00de\u00fau hafi\u00f0 brj\u00f3staverk, hamrandi e\u00f0a \u00f3reglulegan hjartsl\u00e1tt, mikinn h\u00f6fu\u00f0verk, e\u00f0a yfirli\u00f0 \u00ed e\u00f0a eftir IV NAD+ innrennsli.
  • \u00de\u00edn h\u00fadi\u00f0 e\u00f0a augu ver\u00f0a gul, \u00fev\u00ed \u00fev\u00ed\u00f0u\u00f0 gulnar, e\u00f0a \u00feu\u00f0 hafi\u00f0 mikinn verk \u00ed efra h\u00e1gra me\u00f0alhluta.
  • Ro\u00f0i kemur me\u00f0 svima, hra\u00f0an hjartsl\u00e1tt, e\u00f0a yfirli\u00f0, frekar en venjulegan v\u00e6gan hita.

\u00B\u00f3ka\u00f0 heims\u00f3kn innan viku ef:

  • \u00d3gle\u00f0i e\u00f0a h\u00f6fu\u00f0verkur heldur \u00e1fram jafnvel eftir a\u00f0 \u00feu\u00f0 minnka\u00f0i skammtinn.
  • \u00de\u00edn heimilisgl\u00fakk\u00f3sa l\u00e9ttir upp eftir a\u00f0 hafa byrja\u00f0 formverki.
  • \u00d3\u00f6r\u00f6r\u00f0ur \u00fereyta e\u00f0a n\u00fdtt \u00fara\u00f0 heldur \u00e1fram \u00e1 jafnan skammti.

\u00R\u00e6ttu vi\u00f0 l\u00e6kni \u00e1\u00f0ur en \u00feu\u00f0 byrjar ef:

  • \u00de\u00fau hafi\u00f0 virkt e\u00f0a fyrri krabbamein. F\u00e1\u00f0u \u00fe\u00edna krabbameinsl\u00e6kni \u00e1lit fyrst, \u00ed \u00f6ryggi \u00f3leystu krabbameins-aukandi merki.
  • \u00de\u00fau s\u00e9u \u00f3l\u00f6glegar e\u00f0a me\u00f0gengnar.
  • \u00de\u00fau hafi\u00f0 n\u00edru- e\u00f0a lifrarbilun.
  • \u00de\u00fau taki\u00f0 sykurs\u00faki lyf, stat\u00edn e\u00f0a storkulyf.

Ef \u00feu\u00f0 ert ekki viss hva\u00f0 stig \u00feu\u00f0 ert \u00ed, \u00f3keypis August AI Einkennasko\u00f0ari mun lei\u00f0a \u00feig \u00ed\u00f0ur \u00f3t\u00f6k spurningar \u00ed nokkrar m\u00edn\u00f3tur og bendi \u00feig \u00e1 vi\u00f0eigandi \u00f3t\u00f6k stig.

Algengar spurningar

Er NMN enn l\u00f6glegt a\u00f0 kaupa \u00ed Bandar\u00edkjunum?

J\u00e1. NMN er \u00e1 lei\u00f0 \u00ed gegnum FDA's f\u00f3ramarka\u00f0 tilkynninga lei\u00f0 frekar en a\u00f0 vera banna\u00f0 fr\u00e1 s\u00f6lu. FDA's opinber logi af sends 75 daga n\u00fddi\u00e6ttis innihalds tilkynningum s\u00fdnir virka NMN framlag, \u00fear me\u00f0al NDIN #1444 (sent 11/17/2025, FDA svar 1/28/2026) og NDIN #1451 (sent 2/11/2026, svar 4/17/2026). F\u00e1anleiki getur samt veri\u00f0 mismunandi eftir sm\u00f0a og eftir l\u00f6ndum.

Get \u00e9g teki\u00f0 NAD-vi\u00f0b\u00f3tsefni me\u00f0 lyfse\u00f0ilum m\u00ednum?

Stundum, en athuga\u00f0u fyrst frekar en a\u00f0 gera r\u00f6k fyrir. Formlegar samskiptaranns\u00f3knir eru \u00f3þroska\u00f0ar fyrir NR og NMN. Prakt\u00edskar \u00e1hyggjur eru sykurs\u00faki lyf, \u00fear sem gl\u00fakk\u00f3sa \u00e1hrif eru opin spurning, auk stat\u00edna og storkulyfja. Komi\u00f0 me\u00f0 flösku e\u00f0a mynd af mi\u00f0anum til ap\u00f3tekara \u00fe\u00edns, sem getur sko\u00f0a\u00f0 fullan lista \u00fe\u00edn \u00ed nokkrar m\u00edn\u00f3tur \u00f3keypis.

Er d\u00fdrara NAD-vi\u00f0b\u00f3tsefni betra?

Ekki venjulega. Skipti\u00f0 ver\u00f0 eftir heildar milligrömmum af nefndu formverki og ber\u00f0 saman \u00fea\u00f0 t\u00f6lu, ekki flösku ver\u00f0. \u00deynnsluf\u00f6rm og undir tungu f\u00f6rm rukka raunverulegt for\u00f0r\u00f3tt um uppt\u00f6kua\u00f0 kr\u00f6fur n\u00e1lega 60 pr\u00f3sent \u00e1 m\u00f3ti 10 til 20 pr\u00f3sent fyrir venjulega munnsognu, sem getur r\u00f6ksett a\u00f0 borga nokku\u00f0 meira. \u00dea\u00f0 r\u00f6ksetur ekki a\u00f0 borga \u00ferisvar fyrir \u00f3votta\u00f0 v\u00f6ru.

Get \u00e9g teki\u00f0 NMN og NR sam\u00e1n?

Ekki venjulega \u00fea\u00f0 vir\u00f0i. B\u00e1\u00f0ir gefa sama bj\u00f6rgunarferli, og engin ranns\u00f3kn \u00e1 m\u00e6li hefur pr\u00f3fa\u00f0 samsetningu \u00e1 m\u00f3ti hvorri fyrir sig einni. St\u00f3kkun eykur flestar \u00fea\u00f0 heildarskammta og m\u00f3na\u00f0ar kostna\u00f0 \u00fea\u00f0 me\u00f0an \u00feu\u00f0 ver\u00f0ur \u00f3m\u00f6gulegt a\u00f0 vita hva\u00f0 v\u00f6ru olli \u00e1vinningi e\u00f0a hli\u00f0arverkun. Keyra eitt \u00ed einu.

\u00dearf \u00e9g a\u00f0 hringja af NAD-vi\u00f0b\u00f3tsefni?

Nei. Engin sönnun er fyrir \u00feoli, sem hringir myndi endurstilla, og engin ranns\u00f3kn hefur bori\u00f0 saman samfellda vi\u00f0 hlutbundna notkun. \u00dea\u00f0 sem gerir skyn er reglulegt endurmat: \u00e1 sex m\u00e1nu\u00f0a fresti, sta\u00f0festu a\u00f0 \u00feu\u00f0 f\u00e6rir enn eitthva\u00f0 sem \u00feu\u00f0 getur nefnt fr\u00e1 \u00fev\u00ed, \u00fear sem mannlegt \u00f6ryggismat n\u00e1r yfir vikur til nokkra m\u00e1nu\u00f0a.

\u00e1 \u00e9g a\u00f0 borga fyrir NAD+ bl\u00f3\u00f0pr\u00f3f til a\u00f0 sj\u00e1 hvort \u00fea\u00f0 virki?

Ekki venjulega. Bl\u00f3\u00f0 NAD+ er ranns\u00f3knar endapunktur, og ranns\u00f3knir notu\u00f0u \u00fea\u00f0 n\u00e1kv\u00e6mlega vegna \u00fea\u00f0 hreyfist sp\u00e1tt me\u00f0 skammti. Enginn sta\u00f0festur markmi\u00f0stigi er bundinn vi\u00f0 hvernig \u00feu\u00f0 finnur e\u00f0a vi\u00f0 hva\u00f0 sem er kl\u00edniskt \u00fatraun, svo ni\u00f0urst\u00f6\u00f0 sta\u00f0festir mestmegnis a\u00f0 \u00feu\u00f0 hafi\u00f0 sogi\u00f0 hylki\u00f0. Ey\u00f0u \u00fea\u00f0 p\u00edningum \u00e1 \u00f3trygg\u00f0ri v\u00f6ru \u00ed sta\u00f0.

Get \u00e9g fengi\u00f0 n\u00f3g NAD+ fr\u00e1 mat frekar en vi\u00f0b\u00f3tsefni?

Nei, ekki \u00e1 vi\u00f0b\u00f3tsefni stigum. Kjöt, fiskur, alifuglar, belgjurtir og styrkt korn birgja n\u00f3g B3 til a\u00f0 for\u00f0ast skort og sty\u00f0ja e\u00f0lilegt NAD+ umturnun, sem er annar markmi\u00f0. A\u00f0 n\u00e1 250 til 500 mg \u00e1 dag fr\u00e1 mat er ekki raunh\u00e6ft, \u00fear sem \u00fea\u00f0 efra inntaka stig fyrir n\u00edasin sj\u00e1lft situr \u00e1 35 mg \u00e1 dag.

Ni\u00f0urstai\u00f0an

Kaupa \u00f3trygg\u00f0a NMN e\u00f0a NR v\u00f6ru, byrja \u00e1 250 mg \u00e1 hverjum morgni, halda tv\u00ed vikur, og \u00edhuga 300 til 500 mg bara ef \u00feu\u00f0 \u00feolir \u00fea\u00f0 og hefur \u00e1st\u00e6\u00f0u. Fylgjast me\u00f0 einum e\u00f0a tveimur \u00fatraunum og d\u00f3ma eftir fj\u00f3rur til sex vikur. NAD vi\u00f0b\u00f3tsefni er sanngjarnt, l\u00edt\u00f6\u00f0 \u00f3ttyggt tilraun \u00ed efnaskiptastu\u00f0ningi, ekki sönnu\u00f0 lei\u00f0 til a\u00f0 eldast \u00f3hra\u00f0ar.

\u00Fyrirvari: \u00deessi grein er eing\u00f6ngu \u00ed uppl\u00fdsingaskyni og telst ekki l\u00e6kningarr\u00e1\u00f0. R\u00e6ttu alltaf vi\u00f0 h\u00e6filegan heilbrig\u00f0isstarfsmann til \u00e1kv\u00e6mda greiningar og me\u00f0fer\u00f0ar. Ef \u00feu\u00f0 finnur fyrir ney\u00f0artilfelli, hringdu \u00e1 911 e\u00f0a far\u00f0u \u00e1 n\u00e6sta br\u00e1\u00f0a\u00f0astofu strax.